SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-151975
Filing Date
2017-05-01
Accepted
2017-05-01 16:35:57
Documents
3
Period of Report
2017-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d340071d8k.htm 8-K 15572
2 EX-99.1 d340071dex991.htm EX-99.1 63968
3 GRAPHIC g340071g0429110044997.jpg GRAPHIC 4524
  Complete submission text file 0001193125-17-151975.txt   87077
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 17801285
SIC: 2834 Pharmaceutical Preparations